SU015
SU015 (DOTA-RGDfK dimer) is a Integrin αvβ5 and αvβ3 antagonist. SU015 exhibits comparable affinity for αvβ5 and αvβ3, with relatively higher potency and specificity compared to other integrins. SU015 inhibits αvβ3-mediated cell adhesion to fibrinogen, αvβ3-mediated adhesion of activated platelets to osteopontin, and αvβ5-mediated cell adhesion to vitronectin. SU015 shows potent inhibitory effects on FGF2-induced angiogenesis in the CAM model. SU015 carries a linker arm available for radioisotope conjugation, and acts as a target-specific radioreagent when labeled with 90Y (i.e., RP697) or 177Lu (i.e., RP688). SU015 can be used in studies related to tumor metastasis and tumors.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 250612-06-7
- 分子式: C75H113N23O23
- 分子量:1704.84
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
Radionuclide-Drug Conjugates (RDCs) アイソフォーム固有の製品をすべて表示
More
生物活性
|
αvβ3 |
αvβ5 |
SU015 (0.1-100 μM; 15 min) inhibits αvβ3-mediated adhesion of HUVEC cells to fibrinogen, with an IC50 of 0.21 μM[1].
SU015 (0.1-100 μM; 15 min) inhibits αvβ3-mediated adhesion of 293/β3-transfected CHO cells to fibrinogen, with an IC50 of 0.32 μM[1].
SU015 (0.1-100 μM; 15 min) inhibits the αvβ3-mediated adhesion of activated human platelets to osteopontin, with an IC50 of 0.63 μM[1].
SU015 (0.1-100 μM; 15 min) inhibits αvβ5-mediated adhesion of SK-BR-3 cells to vitronectin with an IC50 of 0.50 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:10-day-old embryos[1]
-
Dosage:3.75 μg; 7.5 μg
-
Administration:topical application
-
Result:Inhibited fibroblast growth factor-2-induced angiogenesis by 55% at 3.75 μg.
Inhibited fibroblast growth factor-2-induced angiogenesis by 88% at 7.5 μg.
化学情報
-
CAS 番号 250612-06-7
-
分子量 1704.84
-
分子式 C75H113N23O23
-
SMILES
O=C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N1)=O)CC(O)=O)=O)=O)CCCNC(N)=N)=O)CCCCNC([C@H](CCC(NCCCC[C@@H]2NC([C@H](NC([C@@H](NC(CNC([C@@H](NC2=O)CCCNC(N)=N)=O)=O)CC(O)=O)=O)CC3=CC=CC=C3)=O)=O)NC(CN4CCN(CCN(CCN(CC4)CC(O)=O)CC(O)=O)CC(O)=O)=O)=O)[C@H]1CC5=CC=CC=C5
-
別名
DOTA-RGDfK dimer
-
配列
DOTA-di(Arg-Gly-Asp-{D-Phe}-Lys)
-
シーケンスの短縮
DOTA-di(RGD-{D-Phe}-K)
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Wright T. αv Integrin Affinity/Specificity and Antiangiogenesis Effect of a Novel Tetraaza Cyclic Peptide Derivative, SU015, in Various Species: Retraction. J Cardiovasc Pharmacol. 2023 Aug 23. [Content Brief]
[2]. Liu S, et al. (90)Y and (177)Lu labeling of a DOTA-conjugated vitronectin receptor antagonist useful for tumor therapy. Bioconjug Chem. 2001;12(4):559-568. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Powered by Bioz